Phathom Pharmaceuticals (PHAT) Change in Inventory (2023 - 2026)
Phathom Pharmaceuticals (PHAT) reported Change in Inventory of -$665000.0 for Q1 2026, down 105.39% year-over-year from $12.3 million in Q1 2025, and up 66.78% quarter-over-quarter from -$2.0 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) Change in Inventory (2023 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 4 years of Change in Inventory data on file, last reported at -$665000.0 in Q1 2026.
- Change in Inventory for Q1 2026 came in at -$665000.0, down 105.39% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 million (down 106.71% YoY), and the FY2025 annual result was $11.8 million, up 91.81% from the prior year.
- Change in Inventory advanced to -$665000.0 in Q1 2026 per PHAT's latest filing, from -$2.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $12.3 million in Q1 2025 and troughed at -$2.0 million in Q4 2025.
- A 4-year average of $2.4 million and a median of $416000.0 in 2024 frame the typical range for Change in Inventory.
- On a YoY basis, Change in Inventory climbed as much as 2863.46% in 2025 and fell as far as 194.5% in 2025.
- A 4-year view of Change in Inventory shows it stood at $9.3 million in 2023, then plunged by 40.24% to $5.6 million in 2024, then plunged by 135.9% to -$2.0 million in 2025, then jumped by 66.78% to -$665000.0 in 2026.
- Business Quant data shows PHAT's Change in Inventory at -$665000.0 in Q1 2026, -$2.0 million in Q4 2025, and -$395000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Phathom Pharmaceuticals | 895.99 Mn | 712.23 Mn | 46.31 Mn | -665,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -665,000.00 |
| Mar 31, 2026 | -665,000.00 |
| Dec 31, 2025 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Sep 30, 2025 | -395,000.00 |
| Sep 30, 2025 | -395,000.00 |
| Jun 30, 2025 | 1.85 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 12.33 Mn |
| Mar 31, 2025 | 12.33 Mn |
| Dec 31, 2024 | 5.58 Mn |
| Dec 31, 2024 | 5.58 Mn |
| Sep 30, 2024 | 418,000.00 |
| Sep 30, 2024 | 418,000.00 |
| Jun 30, 2024 | -268,000.00 |
| Jun 30, 2024 | -268,000.00 |
| Mar 31, 2024 | 416,000.00 |
| Mar 31, 2024 | 416,000.00 |
| Dec 31, 2023 | 9.33 Mn |
| Dec 31, 2023 | 9.33 Mn |